Chapter/Section Purchase

1 Study Coverage
1.1 Critical Care Therapeutics Revenue in Critical Care Therapeutics Business (2017-2022) & (US$ Million) Introduction
1.2 Global Critical Care Therapeutics Outlook 2017 VS 2022 VS 2028
1.2.1 Global Critical Care Therapeutics Market Size for the Year 2017-2028
1.2.2 Global Critical Care Therapeutics Market Size for the Year 2017-2028
1.3 Critical Care Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Critical Care Therapeutics in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Critical Care Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Critical Care Therapeutics Market Dynamics
1.4.1 Critical Care Therapeutics Industry Trends
1.4.2 Critical Care Therapeutics Market Drivers
1.4.3 Critical Care Therapeutics Market Challenges
1.4.4 Critical Care Therapeutics Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Critical Care Therapeutics by Type
2.1 Critical Care Therapeutics Market Segment by Type
2.1.1 Albumin
2.1.2 Prothrombin Complex Concentrates
2.1.3 Antithrombin Concentrates
2.1.4 Factor XIII Concentrates
2.1.5 Fibrinogen Concentrates
2.2 Global Critical Care Therapeutics Market Size by Type (2017, 2022 & 2028)
2.3 Global Critical Care Therapeutics Market Size by Type (2017-2028)
2.4 United States Critical Care Therapeutics Market Size by Type (2017, 2022 & 2028)
2.5 United States Critical Care Therapeutics Market Size by Type (2017-2028)
3 Critical Care Therapeutics by Application
3.1 Critical Care Therapeutics Market Segment by Application
3.1.1 Pulmonary Embolism (PE)
3.1.2 Acute Coronary Syndrome
3.1.3 Atrial Fibrillation
3.1.4 Other
3.2 Global Critical Care Therapeutics Market Size by Application (2017, 2022 & 2028)
3.3 Global Critical Care Therapeutics Market Size by Application (2017-2028)
3.4 United States Critical Care Therapeutics Market Size by Application (2017, 2022 & 2028)
3.5 United States Critical Care Therapeutics Market Size by Application (2017-2028)
4 Global Critical Care Therapeutics Competitor Landscape by Company
4.1 Global Critical Care Therapeutics Market Size by Company
4.1.1 Top Global Critical Care Therapeutics Companies Ranked by Revenue (2021)
4.1.2 Global Critical Care Therapeutics Revenue by Player (2017-2022)
4.2 Global Critical Care Therapeutics Concentration Ratio (CR)
4.2.1 Critical Care Therapeutics Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Critical Care Therapeutics in 2021
4.2.3 Global Critical Care Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Critical Care Therapeutics Headquarters, Revenue in Critical Care Therapeutics Business (2017-2022) & (US$ Million) Type
4.3.1 Global Critical Care Therapeutics Headquarters and Area Served
4.3.2 Global Critical Care Therapeutics Companies Revenue in Critical Care Therapeutics Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Critical Care Therapeutics Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Critical Care Therapeutics Market Size by Company
4.5.1 Top Critical Care Therapeutics Players in United States, Ranked by Revenue (2021)
4.5.2 United States Critical Care Therapeutics Revenue by Players (2020, 2021 & 2022)
5 Global Critical Care Therapeutics Market Size by Region
5.1 Global Critical Care Therapeutics Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Critical Care Therapeutics Market Size by Region (2017-2028)
5.2.1 Global Critical Care Therapeutics Market Size by Region: 2017-2022
5.2.2 Global Critical Care Therapeutics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Critical Care Therapeutics Market Size YoY Growth 2017-2028
6.1.2 North America Critical Care Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Critical Care Therapeutics Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Critical Care Therapeutics Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Critical Care Therapeutics Market Size YoY Growth 2017-2028
6.3.2 Europe Critical Care Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Critical Care Therapeutics Market Size YoY Growth 2017-2028
6.4.2 Latin America Critical Care Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Critical Care Therapeutics Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Critical Care Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 CSL Behring
7.1.1 CSL Behring Company Details
7.1.2 CSL Behring Business Overview
7.1.3 CSL Behring Critical Care Therapeutics Introduction
7.1.4 CSL Behring Revenue in Critical Care Therapeutics Business (2017-2022)
7.1.5 CSL Behring Recent Development
7.2 Grifols
7.2.1 Grifols Company Details
7.2.2 Grifols Business Overview
7.2.3 Grifols Critical Care Therapeutics Introduction
7.2.4 Grifols Revenue in Critical Care Therapeutics Business (2017-2022)
7.2.5 Grifols Recent Development
7.3 Kedrion Biopharma
7.3.1 Kedrion Biopharma Company Details
7.3.2 Kedrion Biopharma Business Overview
7.3.3 Kedrion Biopharma Critical Care Therapeutics Introduction
7.3.4 Kedrion Biopharma Revenue in Critical Care Therapeutics Business (2017-2022)
7.3.5 Kedrion Biopharma Recent Development
7.4 Octapharma
7.4.1 Octapharma Company Details
7.4.2 Octapharma Business Overview
7.4.3 Octapharma Critical Care Therapeutics Introduction
7.4.4 Octapharma Revenue in Critical Care Therapeutics Business (2017-2022)
7.4.5 Octapharma Recent Development
7.5 Takeda
7.5.1 Takeda Company Details
7.5.2 Takeda Business Overview
7.5.3 Takeda Critical Care Therapeutics Introduction
7.5.4 Takeda Revenue in Critical Care Therapeutics Business (2017-2022)
7.5.5 Takeda Recent Development
7.6 Bayer HealthCare
7.6.1 Bayer HealthCare Company Details
7.6.2 Bayer HealthCare Business Overview
7.6.3 Bayer HealthCare Critical Care Therapeutics Introduction
7.6.4 Bayer HealthCare Revenue in Critical Care Therapeutics Business (2017-2022)
7.6.5 Bayer HealthCare Recent Development
7.7 Merck
7.7.1 Merck Company Details
7.7.2 Merck Business Overview
7.7.3 Merck Critical Care Therapeutics Introduction
7.7.4 Merck Revenue in Critical Care Therapeutics Business (2017-2022)
7.7.5 Merck Recent Development
7.8 Mitsubishi Tanabe Pharma
7.8.1 Mitsubishi Tanabe Pharma Company Details
7.8.2 Mitsubishi Tanabe Pharma Business Overview
7.8.3 Mitsubishi Tanabe Pharma Critical Care Therapeutics Introduction
7.8.4 Mitsubishi Tanabe Pharma Revenue in Critical Care Therapeutics Business (2017-2022)
7.8.5 Mitsubishi Tanabe Pharma Recent Development
7.9 REVO Biologics
7.9.1 REVO Biologics Company Details
7.9.2 REVO Biologics Business Overview
7.9.3 REVO Biologics Critical Care Therapeutics Introduction
7.9.4 REVO Biologics Revenue in Critical Care Therapeutics Business (2017-2022)
7.9.5 REVO Biologics Recent Development
7.10 Rockwell Medical
7.10.1 Rockwell Medical Company Details
7.10.2 Rockwell Medical Business Overview
7.10.3 Rockwell Medical Critical Care Therapeutics Introduction
7.10.4 Rockwell Medical Revenue in Critical Care Therapeutics Business (2017-2022)
7.10.5 Rockwell Medical Recent Development
7.11 Thermo Fisher Scientific
7.11.1 Thermo Fisher Scientific Company Details
7.11.2 Thermo Fisher Scientific Business Overview
7.11.3 Thermo Fisher Scientific Critical Care Therapeutics Introduction
7.11.4 Thermo Fisher Scientific Revenue in Critical Care Therapeutics Business (2017-2022)
7.11.5 Thermo Fisher Scientific Recent Development
7.12 Shanghai RAAS
7.12.1 Shanghai RAAS Company Details
7.12.2 Shanghai RAAS Business Overview
7.12.3 Shanghai RAAS Critical Care Therapeutics Introduction
7.12.4 Shanghai RAAS Revenue in Critical Care Therapeutics Business (2017-2022)
7.12.5 Shanghai RAAS Recent Development
7.13 China Biologic Products
7.13.1 China Biologic Products Company Details
7.13.2 China Biologic Products Business Overview
7.13.3 China Biologic Products Critical Care Therapeutics Introduction
7.13.4 China Biologic Products Revenue in Critical Care Therapeutics Business (2017-2022)
7.13.5 China Biologic Products Recent Development
7.14 Cosmo Pharmaceuticals
7.14.1 Cosmo Pharmaceuticals Company Details
7.14.2 Cosmo Pharmaceuticals Business Overview
7.14.3 Cosmo Pharmaceuticals Critical Care Therapeutics Introduction
7.14.4 Cosmo Pharmaceuticals Revenue in Critical Care Therapeutics Business (2017-2022)
7.14.5 Cosmo Pharmaceuticals Recent Development
7.15 King Pharmaceuticals
7.15.1 King Pharmaceuticals Company Details
7.15.2 King Pharmaceuticals Business Overview
7.15.3 King Pharmaceuticals Critical Care Therapeutics Introduction
7.15.4 King Pharmaceuticals Revenue in Critical Care Therapeutics Business (2017-2022)
7.15.5 King Pharmaceuticals Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer